×
For best experience we recommend to activate Javascript in your browser.
Recombinant CSF1R (Axatilimab Biosimilar) antibody
This Human Monoclonal antibody specifically detects CSF1R (Axatilimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.
Catalog No. ABIN7676130
$346.15
Plus shipping costs $50.00
1 mg ABIN7581342
100 μg ABIN7676130
1 mg ABIN7581342
100 μg ABIN7676130
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant CSF1R (Axatilimab Biosimilar) antibody (ABIN7676130)
Target
CSF1R (Axatilimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for CSF1R (Axatilimab Biosimilar) antibodies
Human
Clonality
All clonalities for CSF1R (Axatilimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for CSF1R (Axatilimab Biosimilar) antibodies
This CSF1R (Axatilimab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-CSF1R (Axatilimab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (axatilimab)
Characteristics
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (axatilimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG4 S228P
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for CSF1R (Axatilimab Biosimilar)
(hide)
Target
CSF1R (Axatilimab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
P07333
Recently viewed
(hide)
You are here:
Homepage
Recombinant anti-CSF1R (Axatilimab Biosimilar) antibody (ABIN7676130)
Chat with us , powered by LiveChat